| 摘要 |
A method for atopy prophylaxis involves administering an agent comprising gamma -linolenic acid, dihomo- gamma -linolinic acid, the physiologically compatible salts, esters, amides, phospholipids, glycolipids thereof, and/or prostaglandin E1 (PGE1), PGE1 derivatives, PGE1 analogs to preimmunocompetent humans to prevent the occurrence of atopy. These agents are typically contained in a baby food or are supplied to the baby concurrently. These foods may contain one or more thymus hormones. The use of PGE1, its derivatives and analogs and the physiologically compatible esters, amides, phospholipids and glycolipids thereof in a pharmacologically effective dosage form for the topical or inhalative treatment of acute manifest atopy in the dermal and mucosal areas. These substances are preferably used in combination with gamma -linolinic acid, and dihomo- gamma -linolinic acid, and/or the physiologically compatible salts, esters, amides, phospholipids and glycolipids thereof.
|
